ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 67.38

Change

-0.26 (-0.38)%

Market Cap

CAD 0.22B

Volume

2.29K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.93 (-1.98%)

CAD 3.50B
ZWU:CA BMO Covered Call Utilities ETF

+0.08 (+0.74%)

CAD 1.80B
XIT:CA iShares S&P/TSX Capped Informa..

-2.34 (-3.12%)

CAD 0.89B
TXF:CA First Asset Tech Giants Covere..

-0.63 (-2.84%)

CAD 0.67B
HTA:CA Harvest Tech Achievers Growth ..

-0.49 (-2.57%)

CAD 0.67B
XHC:CA iShares Global Healthcare (CAD..

-0.06 (-0.09%)

CAD 0.56B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.11 (+0.48%)

CAD 0.49B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.14 (+0.50%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

-0.31 (-0.53%)

CAD 0.30B
COW:CA iShares Global Agriculture Com..

+0.16 (+0.24%)

CAD 0.26B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.54% 46% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.54% 46% F 65% D
Trailing 12 Months  
Capital Gain -5.85% 17% F 15% F
Dividend Return 0.68% 25% F 8% B-
Total Return -5.17% 6% D- 13% F
Trailing 5 Years  
Capital Gain 8.17% 34% F 46% F
Dividend Return 2.67% 21% F 5% F
Total Return 10.84% 17% F 30% F
Average Annual (5 Year Horizon)  
Capital Gain 3.12% 31% F 43% F
Dividend Return 3.53% 20% F 38% F
Total Return 0.41% 26% F 24% F
Risk Return Profile  
Volatility (Standard Deviation) 15.67% 63% D 54% F
Risk Adjusted Return 22.54% 17% F 37% F
Market Capitalization 0.22B 65% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.